Key Financial Figures

Financial Performance (₹ in Lakhs):

  • Profit/(Loss) before taxation: (17.09) for FY26 compared to 3.98 in FY25
  • Tax expense: 1.19 (for prior years) for FY26 compared to nil in FY25
  • Profit/(Loss) after taxation: (18.27) for FY26 compared to 3.98 in FY25
  • Transfer from Other Comprehensive Income: 160.95 for FY26
  • Balance carried to Balance Sheet: 182.71 for FY26 compared to 40.03 in FY25

Dividend Declaration:

  • Recommended dividend of ₹87 per equity share of face value ₹10 each
  • Total dividend payout: ₹174 lakhs (subject to shareholder approval)
  • Record date: Friday, 12th June, 2026

Key Balance Sheet Items (as at 31st March, 2026):

  • Total Assets: ₹217.26 lakhs (₹72.84 lakhs in FY25)
  • Equity Share Capital: ₹20.00 lakhs (unchanged)
  • Other Equity: ₹192.44 lakhs (₹50.15 lakhs in FY25)
  • Cash and cash equivalents: ₹209.83 lakhs (₹0.77 lakhs in FY25)
  • Investment Property: ₹0.50 lakhs (unchanged)

Significant Transactions

Sale of Investment:

  • Sold 48,000 equity shares of INOR Medical Products Limited at ₹371.91 per share
  • Total consideration: ₹178.52 lakhs
  • This investment was classified as Fair Value Through Other Comprehensive Income (FVTOCI)
  • The entire gain of ₹178.52 lakhs was recognized in Other Comprehensive Income

AGM Details

Date and Time:

  • Friday, 19th June, 2026 at 12:30 PM (IST)

Venue:

Agenda Items (Ordinary Business):

1. Adoption of Audited Financial Statements for FY 2025-26

2. Declaration of dividend of ₹87 per equity share

3. Re-appointment of Mr. Jairaj Champaklal Bham (DIN: 02806038) as Director retiring by rotation

Shareholder Information:

  • Register of Members closed from 13th June to 19th June 2026
  • E-voting period: 16th June 2026 (9:00 am) to 18th June 2026 (5:00 pm)
  • Scrutinizer: Mr. Vaibhav Shah, Company Secretary

Directors and Key Managerial Personnel

Board Composition:

  • Mr. Jairaj C. Bham (Non-Executive, Non-Independent Director)
  • Mr. Sanjive Arora (Non-Executive, Independent Director)
  • Mr. Nitin H. Datanwala (Non-Executive, Independent Director)
  • Ms. Bakhtavar A. Pardiwalla (Non-Executive, Non-Independent Woman Director)

Changes in Management:

  • Mr. S. Raja resigned as Non-Executive Director w.e.f. 17th June, 2025
  • Mr. Ankush M. Shah resigned as Manager w.e.f. 10th June, 2025
  • Mr. Amit Nisar appointed as Manager w.e.f. 3rd September, 2025

Key Managerial Personnel:

  • Mr. Ganesh S. Pardeshi - Company Secretary and Chief Financial Officer
  • Remuneration: ₹11.69 lakhs for FY26 (10% increase from previous year)

Statutory Auditors:

  • M/s. Manek & Associates, Chartered Accountants
  • Firm Registration Number: 126679W
  • Appointed for 5 years until 48th AGM in 2030
  • Unmodified audit opinion with no qualifications

Secretarial Auditors:

  • M/s. Parikh & Associates, Company Secretaries
  • Clean secretarial audit report

Internal Auditors:

  • M/s. Sandip Shah & Co., Chartered Accountants

Corporate Governance

Board Meetings:

  • 8 meetings held during FY26 on: 29th May, 9th June, 10th June, 11th August, 3rd September, 13th November, 12th February, and 26th February 2026

Committee Composition:

  • Audit Committee: Mr. Sanjive Arora (Chairman), Mr. N.H. Datanwala, Mr. J.C. Bham
  • Nomination and Remuneration Committee: Mr. Sanjive Arora (Chairman), Mr. N.H. Datanwala, Mr. J.C. Bham

Board Evaluation:

  • Annual performance evaluation conducted for Board, its Committees, and individual Directors
  • Separate meeting of Independent Directors held on 12th February, 2026

Capital Structure

Share Capital:

  • Authorized: 200,000 equity shares of ₹10 each
  • Issued, Subscribed and Paid-up: 200,000 equity shares of ₹10 each
  • No change in share capital during the year

Significant Shareholders (as on 31st March, 2026):

  • Nowrosjee Wadia and Sons Limited: 87,243 shares (43.62%)
  • Tristar Charitable Foundation: 38,450 shares (19.23%)
  • Jehangir Nusli Wadia: 14,450 shares (7.23%)

Related Party Transactions

Transactions during FY26:

  • Managerial remuneration to Mr. Ganesh Pardeshi: ₹11.69 lakhs
  • Sale of INOR Medical shares to Nowrosjee Wadia and Sons Limited: ₹178.52 lakhs
  • All transactions were in ordinary course of business and at arm's length

Other Material Information

Compliance Status:

  • No material orders passed by regulators/courts
  • No fraud reported by auditors
  • No pending litigations impacting financial position
  • No deposits accepted from public
  • No CSR obligation (Section 135 not applicable)

Internal Financial Controls:

  • Auditors reported adequate internal financial controls operating effectively

Employee Strength:

  • 1 permanent employee as on 31st March, 2026
  • Median remuneration: ₹11.69 lakhs